Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy-Reference-Cited by-同舟云学术

Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy

Author:

Saadipoor Afshin¹,Razzaghdoust Abolfazl²,Simforoosh Nasser³,Mahdavi Arash⁴,Bakhshandeh Mohsen⁵,Moghadam Maryam⁶,Abdollahi Hamid⁷,Mofid Bahram⁸^ORCID

Affiliation:

1. School of Medicine; Shahid Beheshti University of Medical Sciences; Tehran Iran

2. Urology and Nephrology Research Center, Student Research Committee; Shahid Beheshti University of Medical Sciences; Tehran Iran

3. Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center; Shahid Beheshti University of Medical Sciences; Tehran Iran

4. Department of Radiology, Modarres Hospital; Shahid Beheshti University of Medical Sciences; Tehran Iran

5. Department of Radiology Technology, Allied Medical Faculty; Shahid Beheshti University of Medical Sciences; Tehran Iran

6. Shohada-e-Tajrish Medical Center; Shahid Beheshti University of Medical Sciences; Tehran Iran

7. Department of Medical Physics, School of Medicine; Iran University of Medical Sciences; Tehran Iran

8. Urology and Nephrology Research Center, School of Medicine; Shahid Beheshti University of Medical Sciences; Tehran Iran

Funder

Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences

Behnam Daheshpour Charity Organization

Publisher

Wiley

Subject

Pharmacology

Link

Reference55 articles.

5. The dark side of curcumin;Burgos-Moron;International Journal of Cancer,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献